Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference
Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ET
Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer
Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Enanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024
Enanta Pharma to Participate at Leerink Partners Global Biopharma Conference
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter
Enanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Conference
Enanta to Provide Updates on its Research and Development Programs